Kanwal, Fasiha <br/><br/>
Treatment alternatives for chronic hepatitis B virus infection: a cost-effectiveness analysis.  [electronic resource] 

 -  Annals of internal medicine  May 2005 
 - 821-31 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1539-3704 
<br/><br/><label>Standard No.: </label>10.7326/0003-4819-142-10-200505170-00007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenine--analogs & derivatives<br/>Antiviral Agents--economics<br/>Cost-Benefit Analysis<br/>Decision Support Techniques<br/>Hepatitis B e Antigens--blood<br/>Hepatitis B virus--immunology<br/>Hepatitis B, Chronic--drug therapy<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--economics<br/>Lamivudine--economics<br/>Liver--enzymology<br/>Markov Chains<br/>Organophosphonates--economics<br/>Recombinant Proteins<br/>Salvage Therapy<br/>Sensitivity and Specificity<br/>Transaminases--blood